Chung-Che Tsai1,#, Chih-Hung Lin2,#, Katherine Lin3,4, Jia Hong Hubert Chen4,5, Ying Jie Celia Chen4,5, Ilyssa Ting-Ying Chang3,4, Hsu-Hung Chang6, Jin-Yin Chang7, Tin-Yi Chu8, Po-Chih Hsu4,8,*, Chan-Yen Kuo8,*
BIOCELL, DOI:10.32604/biocell.2025.073698
Abstract Hepatocellular carcinoma (HCC) is a leading cause of cancer-related death worldwide, most commonly driven by chronic hepatitis B virus (HBV) infection. The HBV X protein (HBx) plays a central role in hepatocarcinogenesis by regulating transcription, signal transduction, epigenetic modification, and interactions with noncoding RNAs. This review summarizes current advances in HBx-mediated signaling pathways and mutation-specific functions, highlighting its potential as a prognostic biomarker and therapeutic target, and providing insights for future strategies in HCC treatment and HBV eradication. Activation of nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB), cAMP response element binding protein/activating transcription factor More >
Graphic Abstract